Kawazu 2004.
Study characteristics | |||
Patient sampling | Prospective; consecutive series of patients. Episode‐based analysis | ||
Patient characteristics and setting | 149 participants
Age ranged from 17 to 74 years
70% males
Japan Adults with haematological disorders that were neutropenic, underwent chemotherapy, had persistent fever despite antibiotics, acute graft versus host disease or received corticosteroids. Weekly screening of inpatients Representative spectrum? Yes: adults with haematological disorders that were neutropenic, underwent chemotherapy, had persistent fever despite antibiotics, acute graft versus host disease or received corticosteroids |
||
Index tests | Platelia. Serum was monitored weekly. Treatment episodes with only 1 or 2 measurements were excluded. Positive is either 1 positive sample or 2 consecutive positive samples. All the rest are negative. Cut‐off 0.6 ODI | ||
Target condition and reference standard(s) | Invasive aspergillosis, as defined by the EORTC criteria (Ascioglu 2002) Incorporation avoided? Yes: plasma GM level was not included in the microbiological criteria Acceptable reference standard? Yes: EORTC criteria (Ascioglu 2002) |
||
Flow and timing | Not reported Partial verification avoided? All patients were classified according to the reference criteria Withdrawals explained? N/A Uninterpretable results reported? N/A |
||
Comparative | |||
No patients per category | 9 proven, 2 probable, 13 possible, 125 no IA | ||
Notes | ROC curves and timelines reported Sponsoring precluded? Unclear: nothing reported about support |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Low | Low | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | No | ||
If a threshold was used, was it pre‐specified? | No | ||
High | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Low |